La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Huntington Disease »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Huntingtin Protein < Huntington Disease < Hydrazines  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000246 (2015) E. Baratin [France] ; L. Sugavaneswaran [Canada] ; K. Umapathy [Canada] ; C. Ioana [France] ; S. Krishnan [Canada]Wavelet-based characterization of gait signal for neurological abnormalities.
000335 (2015) Ling Shan [États-Unis] ; Yves Dauvilliers [France] ; Jerome M. Siegel [États-Unis]Interactions of the histamine and hypocretin systems in CNS disorders.
000446 (2014) Anthony H V. Schapira [Royaume-Uni] ; C Warren Olanow [États-Unis] ; J Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
000571 (2014) Mauricio G. Martín [États-Unis] ; Frank Pfrieger [États-Unis] ; Carlos G. Dotti [États-Unis]Cholesterol in brain disease: sometimes determinant and frequently implicated.
000575 (2014) P. Remy [France]Biotherapies in brain diseases: for who, when and how?
000594 (2014) C. Corbier [France] ; M. El BadaouiARMA modelling and nonparametric probability density function of gait signal using L2-L1 estimator in patients with neurodegenerative disease.
000756 (2012) L. Lescaudron [France] ; P. Naveilhan ; I. NeveuThe use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
000A21 (2010) Paolo Gubellini [France] ; Barbara Picconi ; Massimiliano Di Filippo ; Paolo CalabresiDownstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases.
000B84 (2008) Giovanni Stevanin [France] ; Alexis BriceSpinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).
000D50 (2006) Arnaud Delval [France] ; Pierre Krystkowiak ; Jean-Louis Blatt ; Etienne Labyt ; Kathy Dujardin ; Alain Destée [France] ; Philippe Derambure ; Luc Defebvre [France]Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.
000E18 (2005) Guylaine Hoffner [France] ; Philippe DjianTransglutaminase and diseases of the central nervous system.
000F04 (2004) M. Desmurget [France] ; V. Gaveau ; P. Vindras ; R S Turner ; E. Broussolle ; S. ThoboisOn-line motor control in patients with Parkinson's disease.
001110 (2001) M. Peschanski[10 years of substitution therapy for neurodegenerative diseases using fetal neuron grafts: a positive outcome but with questions for the future].
001138 (2001) M. Giménez Y Ribotta [France]Gene therapy strategies in neurodegenerative diseases.
001493 (1995) E. Brouillet [France] ; P. HantrayeEffects of chronic MPTP and 3-nitropropionic acid in nonhuman primates.
001510 (1994) A. Autret [France] ; B. Lucas ; F. Henry ; D. Saudeau ; B. De Toffol[The influence of sleep on abnormal waking movements].
001525 (1994) F. Pasquier [France] ; M. Van Der Linden ; V. Lefebvre ; C. Lefebvre ; R. Bruyer ; H. PetitMotor memory and the preselection effect in Huntington's and Parkinson's disease.
001548 (1994) B. Pillon [France] ; B. Deweer ; A. Michon ; C. Malapani ; Yves Agid [France] ; B. DuboisAre explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases.
001583 (1993) B. Pillon [France] ; B. Deweer ; Yves Agid [France] ; B. DuboisExplicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.
001638 (1991) B. Pillon [France] ; B. Dubois ; A. Ploska ; Yves Agid [France]Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
001639 (1991) B. Pillon [France] ; B. Dubois ; Yves Agid [France]Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Huntington Disease" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Huntington Disease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Huntington Disease
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024